根据美国食品药品管理局（FDA）发布的安全警告，患有无肝硬化的原发性胆汁性胆管炎（PBC）的患者使用Ocaliva® （奥贝胆酸）治疗时报告了严重的肝损伤。 Ocaliva 是一种法呢醇 X 受体激动剂，于 2016 年获得加速批准用于治疗 ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

Gallbladder cancer, a highly aggressive disease, often goes undiagnosed until advanced stages due to nonspecific symptoms and lack of routine screening. Risk factors include chronic inflammation, ...

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).

Weight-Loss Surgery Lowers Risk of Developing Complications of Liver Disease in Patients With Cirrhosis and Obesity Jan. 27, 2025 — A study shows that patients with obesity and fatty liver ...

A recent study found that 80 per cent of IT professionals in India have fatty liver, due to work pressure, sedentary ...

Your liver, located on the right side of your body beneath the rib cage, plays a vital role in keeping you healthy. However, ...

Here are a selection of notices published earlier this week: ...

Cirrhosis is a pathological diagnosis characterised by diffuse fibrosis, severe disruption of the intrahepatic arterial and venous flow, portal hypertension and, ultimately, liver failure.1 ...